Recent studies have shown that the matrix metallopeptidase 9 (MMP9) promoter methylation level is significantly reduced while the runt-related transcription factor 3 (RUNX3) promoter methylation level is significantly heightened in SLE PBMCs compared to healthy controls. This evidence concerns the gene RUNX3 and systemic lupus erythematosus.